Bartalucci Niccolò (Niccolo Bartalucci, Niccolò Bartalucci)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Leukemia

American journal of hematology

Scientific reports

Expert review of anticancer therapy

University of Florence (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Florence

Italy

PHD :: Department of Experimental and Clinical Medicine

Publications

Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia (2024)
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia 38 (9) (2024)
Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Bartalucci Niccolò, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Maria Vannucchi, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini, Alessandro Malara
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis. Leukemia 38 (9) (2024)
Laura Calabresi, Chiara Carretta, Simone Romagnoli, Giada Rotunno, Sandra Parenti, Matteo Bertesi, Bartalucci Niccolò, Sebastiano Rontauroli, Chiara Chiereghin, Sara Castellano, Giulia Gentili, Chiara Maccari, Fiorenza Vanderwert, Francesco Mannelli, Matteo Della Porta, Rossella Manfredini, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms. American journal of hematology (2023)
Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Margherita Mirabile, Francesca Pedrazzi, Elena Genovese, Stefano Sartini, Massimiliano Dall'Ora, Giulia Grisendi, Luca Fabbiani, Monica Maccaferri, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Bartalucci Niccolò, Laura Calabresi, Manjola Balliu, Paola Guglielmelli, Leonardo Potenza, Enrico Tagliafico, Lorena Losi, Massimo Dominici, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model. Leukemia (2023)
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Bartalucci Niccolò, Alessandro Maria Maria Vannucchi
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood advances 6 (9) (2022)
Maria Elena Melica, Giulia Antonelli, Roberto Semeraro, Maria-Lucia Angelotti, Gianmarco Lugli, Samuela Landini, Fiammetta Ravaglia, Gilda La Regina, Carolina Conte, Letizia De Chiara, Anna Julie Peired, Benedetta Mazzinghi, Marta Donati, Alice Molli, Stefanie Steiger, Alberto Magi, Bartalucci Niccolò, Valentina Raglianti, Francesco Guzzi, Laura Maggi, Francesco Annunziato, Alexa Burger, Elena Lazzeri, Hans-Johachim Anders, Laura Lasagni, Paola Romagnani
Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice. Science translational medicine 14 (657) (2022)
Aaron T Gerds, Bartalucci Niccolò, Albert Assad, Abdulraheem Yacoub
Targeting the PI3K pathway in myeloproliferative neoplasms. Expert review of anticancer therapy 22 (8) (2022)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesco Mannelli, Barbara Mora, Carmela Mannarelli, Giada Rotunno, Fabiana Pancani, Chiara Maccari, Bartalucci Niccolò, Simone Romagnoli, Giacomo Coltro, Francesco Passamonti, Alessandro Maria Maria Vannucchi
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates. American journal of hematology 97 (9) (2022)
Simona Salati, Elena Genovese, Chiara Carretta, Roberta Zini, Bartalucci Niccolò, Zelia Prudente, Valentina Pennucci, Samantha Ruberti, Chiara Rossi, Sebastiano Rontauroli, Elena Enzo, Laura Calabresi, Manjola Balliu, Carmela Mannarelli, Elisa Bianchi, Paola Guglielmelli, Enrico Tagliafico, Alessandro M Vannucchi, Rossella Manfredini
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants. Scientific reports 9 (1) (2019)
Paola Guglielmelli, Annalisa Pacilli, Giacomo Coltro, Francesco Mannelli, Lara Mannelli, Elisa Contini, Giada Rotunno, Bartalucci Niccolò, Sara Fiaccabrino, Benedetta Sordi, Giuseppe Gaetano Loscocco, Chiara Paoli, Alessandro Maria Maria Vannucchi
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms. American journal of hematology 95 (1) (2019)
Annalisa Pacilli, Giada Rotunno, Carmela Mannarelli, Tiziana Fanelli, Alessandro Pancrazzi, Elisa Contini, Francesco Mannelli, Francesca Gesullo, Bartalucci Niccolò, Giuditta Corbizi Fattori, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea. Blood cancer journal 8 (12) (2018)
Chiara Rossi, Roberta Zini, Sebastiano Rontauroli, Samantha Ruberti, Zelia Prudente, Greta Barbieri, Elisa Bianchi, Simona Salati, Elena Genovese, Bartalucci Niccolò, Paola Guglielmelli, Enrico Tagliafico, Vittorio Rosti, Giovanni Barosi, Alessandro Maria Maria Vannucchi, Rossella Manfredini, null null
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis. Molecular oncology 12 (12) (2018)

Bartalucci Niccolò.css-eqlu8i{font-size:small;padding-left:4px;} (Niccolo Bartalucci, Niccolò Bartalucci)

Publication Activity (10 Years)

Top Topics

Top Venues

Bartalucci Niccolò (Niccolo Bartalucci, Niccolò Bartalucci)